Please login to the form below

Not currently logged in

Text messaging fails to change stance on flu vaccine

US study of low-income, pregnant women indicates texting ineffective in changing willingness to have flu vaccine

The results of the US pilot study published in Obstetrics & Gynecology have concluded that text messaging prompts were not effective at increasing influenza vaccination rates among a low-income, urban, obstetric population who had previously refused the vaccination.

The randomised, controlled clinical trial appears on the US National Institutes of Health's registry and sampled primarily African American (66 per cent) with low educational attainment (90 per cent having equivalent to or less than high school education) and carried no healthcare insurance. The sample had previously declined having the flu vaccine.

Between 2010 and 2011, researchers sent 12 weekly text messages to 158 women in the study group.

The purpose of the study was to try and establish an effective way to educate pregnant women about their particular vulnerability to influenza infection and increase vaccine uptake.

The use of text messaging as a simple prompt is already having some success in helping people quit smoking and manage chronic conditions, such as diabetes and there is also interest in this communication method to increase adherence.

Texting also appears to carry a higher success rate among those who are already willing to get vaccinated.

However, clinical studies suggest that a broader communication strategy is called for if the objective is to educate and change mindset of audiences.

3rd April 2013

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...